Please sign in to follow a disease.
Chlamydia infectious disease
MONDO:0021697Infections with bacteria of the genus CHLAMYDIA.
Also known as: Chlamydia caused disease or disorder, Chlamydia disease or disorder, Chlamydia infectious disease, Chlamydophila caused disease or disorder, Chlamydophila disease or disorder, chlamydia infectious disease, Chlamydia infection, infection, Chlamydia
98 clinical trials for this condition and its sub-types.
Follow this condition — get notified about new trialsSub-types
Broader categories
-
Could halting antibiotic distributions end trachoma for good?
Disease control TerminatedThis study aimed to see if communities with low levels of trachoma could stop receiving yearly azithromycin treatments without the infection coming back. Researchers planned to compare groups that continued or stopped the medicine over three years. However, the trial was withdraw…
Phase: PHASE4 • Sponsor: University of California, San Francisco • Aim: Disease control
Last updated Jun 27, 2026 11:01 UTC
-
Hospital at home: new study tests home care for infections
Disease control OngoingThis study looks at whether a special team of doctors and nurses can treat adults with suspected infections at home, instead of sending them to the hospital. About 500 people will be randomly assigned to either standard hospital care or home-based care from a mobile response team…
Phase: NA • Sponsor: Copenhagen University Hospital at Herlev • Aim: Disease control
Last updated Jun 27, 2026 11:00 UTC
-
Personalized antibiotic dosing may boost infection treatment
Disease control OngoingThis study tests whether using personalized dosing (based on drug levels in the blood) for the antibiotic teicoplanin works better than standard dosing for treating bacterial infections. About 74 adults in hospital intensive care or other units will take part. The goal is to see …
Phase: PHASE4 • Sponsor: Radboud University Medical Center • Aim: Disease control
Last updated Jun 27, 2026 09:06 UTC
-
New tetracycline drugs take on superbugs in Real-World trial
Disease control ENROLLING_BY_INVITATIONThis real-world study is testing two neotetracycline drugs, eravacycline and tigecycline, in 300 adults with drug-resistant Gram-negative bacterial infections. Researchers will track how well the drugs clear the infection and monitor for side effects. The goal is to see if these …
Sponsor: The First Affiliated Hospital with Nanjing Medical University • Aim: Disease control
Last updated Jun 27, 2026 08:09 UTC
-
Could a simple cup cut STIs and BV? new trial hopes so
Disease control OngoingThis study tests whether giving menstrual cups to economically vulnerable women in Kenya can lower rates of bacterial vaginosis (BV) and sexually transmitted infections (STIs). The cup is a reusable silicone device that collects menstrual blood and can be worn during sex. Researc…
Phase: PHASE2 • Sponsor: Rush University Medical Center • Aim: Disease control
Last updated Jun 27, 2026 08:07 UTC
-
Can targeted antibiotic rounds wipe out blinding eye disease?
Disease control OngoingThis study tests whether giving antibiotics more often to entire communities can eliminate trachoma, an eye infection that can cause blindness. Over 300,000 people in Ethiopia are taking part. The goal is to see if this intensive approach works better than the current yearly trea…
Phase: PHASE4 • Sponsor: University of California, San Francisco • Aim: Disease control
Last updated Jun 27, 2026 07:55 UTC
-
Can a common antibiotic prevent STIs? new study tests two dosing strategies
Prevention OngoingThis study tests whether taking doxycycline before potential exposure to STIs works better than taking it after exposure. 300 men who have sex with men will be randomly assigned to one of two groups and followed for 2 years. The goal is to see which approach better prevents chlam…
Phase: PHASE4 • Sponsor: Chinese University of Hong Kong • Aim: Prevention
Last updated Jun 27, 2026 13:02 UTC
-
AI predicts hospital stays, but study never started
Knowledge-focused TerminatedThis study aimed to see if a computer could learn to predict how long a patient would stay in a home hospital program. Researchers planned to use data from past patients to train the computer. However, the study was withdrawn before any patients were enrolled, so no results are a…
Sponsor: Brigham and Women's Hospital • Aim: Knowledge-focused
Last updated Jun 27, 2026 11:03 UTC
-
Inside the ICU: new study tracks tough pneumonia cases
Knowledge-focused OngoingThis study follows 100 adults hospitalized in intensive care units with severe pneumonia caused by Mycoplasma or Chlamydia bacteria. Researchers will track how patients are treated, how long they stay in the hospital, and how many survive. They will also check for antibiotic resi…
Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Knowledge-focused
Last updated Jun 27, 2026 11:02 UTC
-
Immune cell showdown: autoimmune vs. infection vs. healthy
Knowledge-focused ENROLLING_BY_INVITATIONThis study looks at immune cells from people with autoimmune diseases (like lupus), people with infections, and healthy volunteers. Researchers want to understand how these cells differ and what makes them attack the body in autoimmune conditions. The study involves blood and bon…
Sponsor: Emory University • Aim: Knowledge-focused
Last updated Jun 27, 2026 07:53 UTC